Cescon, D.W., Bradbury, P.A., Asomaning, K., Hopkins, J., Zhai, R., Zhou, W., Wang, Z., Kulke, M., Su, L., Ma, C., Xu, W., Marshall, A.L., Heist, R.S., Wain, J.C., Lynch Jr., T.J., Christiani, D.C. and Liu, G. (2009) p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer Prognosis. Clinical Cancer Research, 15, 3103-3109.
http://dx.doi.org/10.1158/1078-0432.CCR-08-3120

has been cited by the following article:

• TITLE: MDM2 SNP309 (rs2279744) and p53 Codon Arg72Pro (rs1042522) SNP in Cervical Carcinogenesis

  AUTHORS: Osamu Nunobiki, Hirohide Sawada, Masatsugu Ueda

  KEYWORDS: p53, MDM2, Polymorphism, HPV, Cervical Carcinogenesis

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.5 No.7, June 20, 2014

  ABSTRACT: To investigate the association between polymorphisms (SNP) in the p53 and murine double minute 2 homolog (MDM2) promoter 309 in cervical carcinogenesis. SNP at p53 codon 72 polymorphisms and MDM2 promoter 309 (T/G) together with human papillomavirus (HPV) types were examined in a total of 187 cervical smear samples using real time PCR. 27 cases with HPV types 16 and/or 18 had significantly higher frequency of the TG + GG genotype and G allele than 56 with other types of high-risk HPV (P = 0.0136). 48 cases with HPV types 52 and/or 58 had significantly higher frequency of the TG + GG genotype and G allele than 56 with other types of high-risk HPV (P = 0.001). Our studies have demonstrated that the frequency of G allele in MDM2 promoter 309 increased from LSIL to HSIL and that there was an increased OR for G allele in HSIL cases with high-risk HPV types including 52 and 58. It is known that geographically different oncogenic HPV types 52 and 58 are more prevalent than 16 and 18 in a Japanese population.